Chemoinformaics analysis of DIHYDROPALMATINIUM HYDROXIDE
| Molecular Weight | 371.433 | nRot | 4 |
| Heavy Atom Molecular Weight | 346.233 | nRig | 21 |
| Exact Molecular Weight | 371.173 | nRing | 4 |
| Solubility: LogS | -3.966 | nHRing | 2 |
| Solubility: LogP | 2.797 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 56.8498 |
| nHD | 0 | BPOL | 32.8662 |
| QED | 0.792 |
| Synth | 2.98 |
| Natural Product Likeliness | 0.764 |
| NR-PPAR-gamma | 0.097 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.598 |
| Pgp-sub | 0.993 |
| HIA | 0.004 |
| CACO-2 | -5.249 |
| MDCK | 0.0000281 |
| BBB | 0.751 |
| PPB | 0.794817 |
| VDSS | 1.145 |
| FU | 0.114295 |
| CYP1A2-inh | 0.154 |
| CYP1A2-sub | 0.817 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.896 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.521 |
| CYP2d6-inh | 0.298 |
| CYP2d6-sub | 0.9 |
| CYP3a4-inh | 0.07 |
| CYP3a4-sub | 0.797 |
| CL | 9.981 |
| T12 | 0.68 |
| hERG | 0.07 |
| Ames | 0.069 |
| ROA | 0.219 |
| SkinSen | 0.217 |
| Carcinogencity | 0.037 |
| EI | 0.012 |
| Respiratory | 0.309 |
| NR-Aromatase | 0.533 |
| Antiviral | Yes |
| Prediction | 0.536258 |